Büttner, F.A.* et al. Abstract 7155: A PD-L1-independent phenotype uncovers responders to combined therapy with immune checkpoint inhibitors in kidney cancer. Cancer Res. 85, 7155 - 7155 (2025)
Hains, A.E.* et al. Abstract SY23-01: Diffuse midline gliomas: From cell cycle to therapeutic opportunities. Cancer Res. 85, SY23 - 01 (2025)
Papargyriou, A. & Reichert, M.* The biology in the pattern: Metastatic organotropism and clinical outcome depend on DNA damage response and immune interactions in pancreatic cancer. Cancer Res. 85, 1571-1573 (2025)
Du, M.* et al. CYP2A6 activity and cigarette consumption interact in smoking-related lung cancer susceptibility. Cancer Res. 84, 616-625 (2024)
Turnham, R.E.* et al. HBV remodels PP2A complexes to rewire kinase signaling in hepatocellular carcinoma. Cancer Res., DOI: 10.1158/0008-5472.CAN-24-0456 (2024)
Kunzke, T. et al. Patterns of carbon-bound exogenous compounds in lung cancer patients and association with disease pathophysiology. Cancer Res. 81, 5862-5875 (2021)
Schoeps, B.* et al. Timp1 triggers neutrophil extracellular trap formation in pancreatic cancer. Cancer Res. 81, 3568-3579 (2021)
Banga, J.* et al. Predictive modeling, applied to genetically engineered mouse models of breast or lung cancer, provides insights into major oncogenic pathways. Cancer Res. 80, 35-35 (2020)
Baumeister, S. et al. Physical activity does not lower the risk of lung cancer. Cancer Res. 80, 3765-3769 (2020)
Liapis, E. ; Klemm, U. ; Karlas, A. ; Reber, J. & Ntziachristos, V. Resolution of spatial and temporal heterogeneity in bevacizumab-treated breast tumors by eigenspectra multispectral optoacoustic tomography. Cancer Res. 80, 5291-5304 (2020)
Scheel, C. Cell fate plasticity during breast cancer development - where is the translational utility? Cancer Res. 80:ES10-3 (2020)
Timofeev, O.* et al. Phosphorylation control of p53 DNA binding cooperativity balances tumorigensis and aging. Cancer Res. 80, 5231-5244 (2020)
Bianco, G.* et al. HOXA13 drives hepatocytes proliferation and liver tumorigenesis in mice. Cancer Res. 79 (2019)
Ron, A. ; Dean-Ben, X.L. ; Gottschalk, S. & Razansky, D. Volumetric optoacoustic imaging unveils high-resolution patterns of acute and cyclic hypoxia in a murine model of breast cancer. Cancer Res. 79, 4767-4775 (2019)
Shah, R.* ; Singh, S.J.* ; Eddy, K.* ; Filipp, F.V. & Chen, S.* Concurrent targeting of glutaminolysis and metabotropic glutamate receptor 1 (GRM1) reduces glutamate bioavailability in GRM1(+) melanoma. Cancer Res. 79, 1799-1809 (2019)
Lordick, F.* et al. Heterogeneity of HER2 expression in gastric cancer (GC) leads to high deviation rates between local and central testing and hampers efficacy of anti-HER2 therapy: Survival results from the VARIANZ study. Cancer Res. 78 (2018)
Magkrioti, C.* et al. The autotaxin - lysophosphatidic acid axis promotes lung carcinogenesis. Cancer Res. 78, 3634-3644 (2018)
Mueller, S.* et al. Evolutionary trajectories and KRAS gene dosage define pancreatic cancer phenotypes. Cancer Res. 78 (2018)
Mycielska, M.E.* et al. Extracellular citrate affects critical elements of cancer cell metabolism and supports cancer development in vivo. Cancer Res. 78, 2513-2523 (2018)
Schirmer, D.* et al. GPR64-specific CAR-transgenic T cells selectively kill Ewing sarcoma in vivo. Cancer Res. 78 (2018)
Vreka, M. et al. IkB kinase a Is required for development and progression of KRAS-mutant lung adenocarcinoma. Cancer Res. 78, 2939-2951 (2018)
Wierling, C.* et al. CanPathPro-development of a platform for predictive pathway modelling using genetically engineered mouse models. Cancer Res. 78 (2018)
Zoni, E.* et al. Metabolic signature in lethal vs. nonlethal prostate cancer. Cancer Res. 78, 61-62 (2018)
Gires, O. EGFR-dependent regulated intramembrane proteolysis of EpCAM - Letter. Cancer Res. 77, 1775-1776 (2017)
Koch, M. et al. Threshold analysis and biodistribution of fluorescently labeled bevacizumab in human breast cancer. Cancer Res. 77, 623-631 (2017)
Schlenker, R. et al. Chimeric PD-1:28 receptor upgrades low-avidity T cells and restores effector function of tumor-infiltrating lymphocytes for adoptive cell therapy. Cancer Res. 77, 3577-3590 (2017)
Fehringer, G.* et al. Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations. Cancer Res. 76, 5103-5114 (2016)
González-Valllinas, M.* et al. Abstract 1945: Identification of a miRNA/mRNA network driving non-small cell lung cancer (NSCLC) dissemination. Cancer Res. 76 (2016)
Hatzl, S.* et al. Increased expression of miR-23a mediates a loss of expression in the RAF kinase inhibitor protein RKIP. Cancer Res. 76, 3644-3654 (2016)
Mall, S.* et al. Immuno-PET imaging of engineered human T cells in tumors. Cancer Res. 76, 4113-4123 (2016)
Patel, Y.M.* et al. Novel association of genetic markers affecting CYP2A6 activity and lung cancer risk. Cancer Res. 76, 5768-5776 (2016)
Scheel, C. et al. A force-sensitive organoid assay to quantify regenerative potential of single primary human mammary cells. Cancer Res. 76:P1-06-02 (2016)
Wolf, B.* et al. Inducing differentiation of premalignant hepatic cells as a novel therapeutic strategy in hepatocarcinoma. Cancer Res. 76, 5550-5561 (2016)
Anastasov, N. et al. Three-dimensional microtissues as phenotypic screening model to identify radiation modifiers for breast cancer. Cancer Res. 75:1810 (2015)
Bigalke, I.* et al. A new generation of dendritic cells to improve cancer therapy shows prolonged progression-free survival in patients with solid tumors. Cancer Res. 75:2516 (2015)
Höfig, I. et al. Generation of 3D-microtissues suitable for drug screening with lentivirally GFP-labelled CD44+CD24-breast cancer cells enriched by irradiation. Cancer Res. 75:1408 (2015)
Taruttis, A. ; van Dam, G.M.* & Ntziachristos, V. Mesoscopic and macroscopic optoacoustic imaging of cancer. Cancer Res. 75, 1548-1559 (2015)
Toma, M.I.* et al. Accumulation of tolerogenic human 6-sulfo LacNAc plus dendritic cells in renal cell carcinoma is associated with poor prognosis. Cancer Res. 75:1278 (2015)
Endesfelder, D. et al. Chromosomal instability selects gene copy number variants encoding core regulators of proliferation in ER+ breast cancer. Cancer Res. 74, 4853-4863 (2014)
Faucz, F.R.* et al. Constitutive activation of PRKACA in adrenal Cushing's syndrome. Cancer Res. 74:LB-182 (2014)
Hojer, C. et al. B cell expansion and lymphomagenesis induced by chronic CD40 signaling is strictly dependent on CD19. Cancer Res. 74, 4318-4328 (2014)
Leinhäuser, I. et al. The Bone morphogenic protein 7 (Bmp7) plays a pro-tumorigenic role in pheochromocytoma. Cancer Res. 74:4059 (2014)
Morscher, S.* et al. Assessing PK parameters using Dynamic Contrast Enhanced Multispectral Optoacoustic Tomography (DCE-MSOT). Cancer Res. 74:4310 (2014)
Morscher, S.* et al. Novel approaches for dynamic tumor microenvironment imaging by Multispectral Optoacoustic Tomography (MSOT). Cancer Res. 74:2050 (2014)
Stangl, S.* et al. Selective in vivo imaging of tumors with a tumor cell-specific Hsp70 peptide-based probe. Cancer Res. 74, 6903-6912 (2014)
Anastasov, N. et al. Identification of compounds modifying radiation-therapy using a 3D-microtissue technology. Cancer Res. 73:5528 (2013)
Driessen, W.H.P.* et al. Multispectral Optoacoustic Tomography (MSOT) imaging and quantification of apoptosis in vivo. Cancer Res. 73:737 (2013)
Ehrhardt, H. ; Wachter, F. ; Grunert, M. & Jeremias, I. TRAIL induces apoptosis preferentially in cell cycle arrested tumor cells, e.g., in tumor cells from children with acute lymphoblastic leukemia upon knockdown of cyclinE. Cancer Res. 73:3326 (2013)
Gondi, G. et al. Antitumor efficacy of a monoclonal antibody that inhibits the activity of cancer-associated carbonic anhydrase XII. Cancer Res. 73, 6494-6503 (2013)
González-Vasconcellos, I.M. et al. Rb1 haploinsufficiency promotes telomere attrition and radiation-induced genomic instability. Cancer Res. 73, 4247-4255 (2013)
Hauer, K.* et al. DKK2 mediates osteolysis, invasiveness and metastatic spread in Ewing sarcoma. Cancer Res. 73, 967-977 (2013)
Nolte, E.* et al. miR-24 influences proliferation of prostate cancer cells in vitro via targeting ZNF217. Cancer Res. 73:9030 (2013)
Seibold, P.* et al. Enterolactone levels and prognosis after invasive postmenopausal breast cancer: Potential effect modifiers. Cancer Res. 73:115 (2013)
Zhao, Y.* et al. Aspirin decreases side population cells by targeting the Wnt pathway in esophageal cancer cells in vitro and enhances the combination chemotherapeutic effect of 5-FU and cisplatin in vivo. Cancer Res. 73:3717 (2013)
Eissler, N. ; Ruf, P.* ; Mysliwietz, J. ; Lindhofer, H.* & Mocikat, R. Trifunctional bispecific antibodies induce tumor-specific T cells and elicit a vaccination effect. Cancer Res. 72, 3958-3966 (2012)
Gerlach, K.* et al. Transcription factor NFATc2 controls the emergence of colon cancer associated with IL-6-dependent colitis. Cancer Res. 72, 4340-4350 (2012)
Li, Z.* et al. FLT-PET is superior to FDG-PET for very early response prediction in NPM-ALK-positive lymphoma treated with targeted therapy. Cancer Res. 72, 5014-5024 (2012)
Manzoor, A.A.* et al. Overcoming limitations in nanoparticle drug delivery: Triggered, intravascular release to improve drug penetration into tumors. Cancer Res. 72, 5566-5575 (2012)
Prenzel, T.* et al. Estrogen-dependent gene transcription in human breast cancer cells relies upon proteasome-dependent monoubiquitination of histone H2B. Cancer Res. 71, 5739-5753 (2011)
Raia, V.* et al. Dynamic mathematical modeling of IL13-induced signaling in Hodgkin and primary mediastinal B-Cell lymphoma allows prediction of therapeutic targets. Cancer Res. 71, 693-704 (2011)
Rauch, J.* et al. c-Myc regulates RNA splicing of the A-raf kinase and its activation of the ERK pathway. Cancer Res. 71, 4664-4674 (2011)
Mandal, P.K. et al. Loss of thioredoxin reductase 1 renders tumors highly susceptible to pharmacologic glutathione deprivation. Cancer Res. 70, 9505-9514 (2010)
Rauch, J.* et al. Heterogeneous nuclear ribonucleoprotein H blocks MST2-mediated apoptosis in cancer cells by regulating A-Raf transcription. Cancer Res. 70, 1679-1688 (2010)
Schöllnberger, H. ; Beerenwinkel, N.* ; Hoogenveen, R.* & Vineis, P.* Cell selection as driving force in lung and colon carcinogenesis. Cancer Res. 70, 6797-6803 (2010)
Torsvik, A.* et al. Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: Putting the research field on track - letter. Cancer Res. 70, 6393-6396 (2010)
Münz, M.* ; Baeuerle, P.A.* & Gires, O. The emerging role of EpCAM in cancer and stem cell signaling. Cancer Res. 69, 5627-5629 (2009)
Nappi, T.C.* et al. Identification of Polo-like kinase 1 as a potential therapeutic target in anaplastic thyroid carcinoma. Cancer Res. 69, 1916-1923 (2009)
Røsland, G.V.* et al. Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res. 69, 5331-5339 (2009)
Bremm, A.* et al. Enhanced activation of epidermal growth factor receptor caused by tumor-derived E-cadherin mutations. Cancer Res. 68, 707-714 (2008)
Luscher-Firzlaff, J.* et al. The human trithorax protein hASH2 functions as an oncoprotein. Cancer Res. 68, 749-758 (2008)
Ridpath, J.R.* et al. Cells deficient in the FANC/BRCA pathway are hypersensitive to plasma levels of formaldehyde. Cancer Res. 67, 11117-11122 (2007)
Zimmermann, S. et al. Reduced body size and decreased intestinal tumor rates in HDAC2-mutant mice. Cancer Res. 67, 9047-9054 (2007)
Kausche, S.* et al. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8plus T cells. Cancer Res. 66, 11447-11454 (2006)
Nojima, K.* ; Arakawa, H. & Buerstedde, J.-M. Multiple repair pathways mediate tolerance to chemotherapeutic cross-linking agents in vertebrate cells. Cancer Res. 65, 11704-11711 (2005)
Zhou, X.* et al. Diverse CD8+ T-cell responses to renal cell carcinoma antigens in patients treated with an autologous granulocyte-macrophage colony-stimulating factor gene-transduced renal tumor cell vaccine. Cancer Res. 65, 1079-1088 (2005)
Felix, K.* et al. Moderate Hypermutability of a Transgenic lacZ Reporter Gene in Myc-Dependent Inflammation-Induced Plasma Cell Tumors in Mice. Cancer Res. 64, 530-537 (2004)
Felix, K.* et al. Selenium deficiency abrogates inflammation-dependent plasma cell tumors in mice. Cancer Res. 64, 2910-2917 (2004)
Geigl, J.B.* et al. Analysis of gene expression patterns and chromosomal associated with aging. Cancer Res. 64, 8550-8557 (2004)
Hermann, F.* et al. HER-2/neu-mediated regulation of components of the MHC class I antigen-processing pathway. Cancer Res. 64, 215-220 (2004)
Mancuso, M.* et al. Basal cell carcinoma and its development: Insights from radiation-induced tumors in Ptch1-deficient mice. Cancer Res. 64, 934-941 (2004)
Pazzaglia, S.* et al. Modulation of patched-associated susceptibility to radiation induced tumorigenesis by genetic background. Cancer Res. 64, 3798-3806 (2004)
Bukur, J.* et al. Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma. Cancer Res. 63, 4107-4111 (2003)
Dirmeier, U. et al. Latent Membrane Protein 1 is Critical for Efficient Growth Transformation of Human B Cells by Epstein-Barr Virus. Cancer Res. 63, 2982-2989 (2003)
Hartmann, E.* et al. Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer. Cancer Res. 63, 6478-6487 (2003)
Traverso, G.* et al. Hyper-recombination and genetic instability in BLM-deficient epithelial cells. Cancer Res. 63, 8578-8581 (2003)
Bange, J.* et al. Cancer Progression and Tumor Cell Motility Are Associated with the FGFR4 Arg388 Allele. Cancer Res. 62, 840-847 (2002)
Falk, C.S. ; Nößner, E. ; Weiss, E.H.* & Schendel, D.J. Retaliation against Tumor Cells Showing Aberrant HLA Expression Using Lymphokine Activated Killer-derived T Cells1. Cancer Res. 62, 480-487 (2002)
Feuring-Buske, M. ; Frankel, A.E.* ; Alexander, R.L.* ; Gerhard, B.* & Hogge, D.E.* A Diphtheria Toxin-Interleukin 3 Fusion Protein is Cytotoxic to Primitive Acute Myeloid Leukemia Progenitors but Spares Normal Progenitors. Cancer Res. 62, 1730-1736 (2002)
Fritz, A. et al. Recessive Transmission of a Multiple Endocrine Neoplasia Syndrome in the Rat. Cancer Res. 62, 3048-3051 (2002)
Nahta, R.* ; Iglehart, J.D.* ; Kempkes, B. & Schmidt, E.V.* Rate-limiting Effects of Cyclin D1 in Transformation by ErbB2 Predicts Synergy between Herceptin and Flavopiridol. Cancer Res. 62, 2267-2271 (2002)
Egeter, O.* ; Mocikat, R. ; Ghoreschi, K.* ; Dieckmann, A. & Röcken, M.* Eradication of Disseminated Lymphomas with CpG-DNA Activated T Helper Type Cells from Nontransgenic Mice. Cancer Res. 60, 1515-1520 (2000)
Salassidis, K. et al. Translocation t(10;14)(q11.2:q22.1) fusing the kinectin to the RET gene creates a novel rearranged form (PTC8) of the RET proto-oncogene in radiation-induced childhood papillary thyroid carcinoma. Cancer Res. 60, 2786-2679 (2000)
Viluksela, M.* et al. Liver Tumor-promoting Activity of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD-sensitive and TCDD- resistant Rat Strains1. Cancer Res. 60, 6911-6920 (2000)
Luch, A.* et al. The K-region trans-8,9-diol does not significantly contribute as an intermediate in the metabolic activation of dibenzo[a,l]pyrene to DNA-binding metabolites by human cytochrome P450 1A1 or 1B1. Cancer Res. 59, 4603-4609 (1999)
Mocikat, R. ; Selmayr, M. ; Thierfelder, S. & Lindhofer, H. Trioma-based vaccination against B-cell lymphoma confers long-lasting tumor immunity. Cancer Res. 57, 2346-9 (1997)
Zeidler, R. ; Meissner, P.* ; Eissner, G. ; Lazis, S. & Hammerschmidt, W. Rapid proliferation of B cells from adenoids in response to Epstein-Barr virus infection. Cancer Res. 56, 5610-5614 (1996)
Lang, M.* et al. New monoclonal antibodies against the putative immunosuppressive site of retroviral p15E. Cancer Res. 54, 1831-1836 (1994)
Schultz-Hector, S. & Haghayegh, S. β-fibroblast growth factor expression in human and murine squamous cell carcinomas and its relationship to regional endothelial cell proliferation. Cancer Res. 53, 1444-1449 (1993)
Joos, S. et al. Mapping chromosomal breakpoints of Burkitt's t(8;14) translocations far upstream of c-myc. Cancer Res. 52, 6547-6552 (1992)
Jenke, H.-S. ; Michel, G. & Hornhardt, S. Polychlorinated Biphenyls (PCB) Interfere with Cellular Oncogene-Expression in Rat Liver at the Transcriptional Level. Cancer Res. (1990)
Leib-Mösch, C. et al. Endogenous retroviral elements in human DNA. Cancer Res. 50, 17, 5636s-5642s (1990)
Petrides, P.E. ; Bock, S. ; Bovens, J. ; Hofmann, R. & Jakse, G. Modulation of pro-EGF, pro TGF-alpha and EGF-receptor Gene  Expression in Human Renal Carcinoma. Cancer Res. (1990)
Petrides, P.E. ; Bock, S.* ; Bovens, J.* ; Hofmann, R.* & Jakse, G.* Modulation of pro-epidermal growth factor, pro-transforming growth factor α and epidermal growth factor receptor gene expression in human renal carcinomas. Cancer Res. 50, 3934-3939 (1990)
Sturm, S.A. ; Strauß, P.G. ; Adolph, S.* ; Hameister, H.* & Erfle, V.F. Amplification and rearrangement of c-myc in radiation-induced murine osteosarcomas. Cancer Res. 50, 4146-4153 (1990)
Issels, R.D. & Nagele, A. Promotion of cystine uptake, increase of glutathione biosynthesis, and modulation of glutathione status by S-2-(3-aminopropylamino)ethyl phosphorothioic acid (WR-2721) in Chinese hamster cells. Cancer Res. 49, 2082-2086 (1989)
Lauk, S. ; Zietman, A. ; Skates, S. ; Fabian, R. & Suit, H.D. Comparative Morphometric Study of Tumor Vasculature in Human Squamous Cell Carcinomas and Their Xenotransplants in Athymic Nude Mice. Cancer Res. 49, 4557-4561 (1989)
Ellwart, J.W. ; Kremer, J.P. & Dörmér, P.G. Drug testing in established cell lines by flow cytometric vitality measurements versus clonogenic assay. Cancer Res. 48, 5722-5725 (1988)
Issels, R.D. ; Nagele, A. & Wilmanns, W. Promotion of Cystine Uptake, Increase of Glutathione Biosynt hesis, and Modulation of Glutathione Status by S-2-(3-aminopylamino)-ethyl phosphorothioic acid (WR-2721) in Chinese Hamster Cells. Cancer Res. (1988)
Schmidt, J. et al. Characterization of Tumor Cell Heterogenity in Clonal Sublines from a Spontaneous Murine Osteosarcoma. Cancer Res. (1988)
Ziegler, I. ; Hamm, U. & Berndt, J. Participation of pterins in the control of lymphocyte stimulation and lymphoblast proliferation. Cancer Res. 43, 5356-5359 (1983)
Ziegler, I. ; Maier, K.C. & Fink, M.K. Pteridine-binding α1-acid glycoprotein from blood of patients with neoplastic diseases. Cancer Res. 42, 1567-1573 (1982)